Please enable JavaScript to continue using this application.

Compare $CNTN vs $TARA | Chartloom

Compare

$CNTN vs $TARA

Canton Strategic Holdings Inc · Protara Therapeutics Inc

CNTN

Canton Strategic Holdings Inc

TARA

Protara Therapeutics Inc

Compare $CNTN vs $TARA

Comparing Canton Strategic Holdings Inc and Protara Therapeutics Inc

CNTNCanton Strategic Holdings Inc

TARAProtara Therapeutics Inc

CNTNCanton Strategic Holdings Inc

Market cap

$163M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-37.6%

52W performance

-33.6%

FCF yield

-97.9%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTN

TARA

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

CNTN$163M

TARA$155M

Enterprise Value

CNTN$125M

TARA$138M

Price

CNTN$2.11

TARA$2.76

P/E Ratio

CNTNN/A

TARAN/A

P/S Ratio

CNTN108.78x

TARA0.00x

EV/Sales

CNTN83.88x

TARA0.00x

EV/EBITDA

CNTN0.00x

TARA0.00x

P/B Ratio

CNTN0.39x

TARA0.99x

P/FCF Ratio

CNTNN/A

TARAN/A

EV/FCF

CNTN-0.79x

TARA-2.07x

PEG Ratio

CNTNN/A

TARAN/A

Forward P/E (NTM)

CNTNN/A

TARAN/A

Forward P/S (NTM)

CNTNN/A

TARAN/A

Revenue (TTM)

CNTN$1M

TARA$0

Revenue Growth (YoY)

CNTNN/A

TARAN/A

Forward Rev Growth

CNTN0.0%

TARA5488.8%

Gross Margin (TTM)

CNTN0.0%

TARA0.0%

Operating Margin (TTM)

CNTN0.0%

TARA0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

TARA0.0%

Net Margin (TTM)

CNTN-6559.1%

TARA0.0%

FCF Margin (TTM)

CNTN-10651.0%

TARAN/A

Net Income (TTM)

CNTN$-98M

TARA$-70M

FCF (TTM)

CNTN$-159M

TARA$-66M

EPS (TTM)

CNTN-$0.45

TARA-$1.15

ROE (TTM)

CNTN-2954.0%

TARA-4172.0%

ROA (TTM)

CNTN-2342.0%

TARA-3878.0%

ROIC (TTM)

CNTN-2953.0%

TARA-4172.0%

Cash

CNTN$37M

TARA$17M

Debt

CNTN$0

TARA$0

Net Cash/Debt

CNTN$37M

TARA$17M

Current Ratio (TTM)

CNTN15.70x

TARA10.97x

Quick Ratio (TTM)

CNTN14.45x

TARA10.81x

Debt/Equity (TTM)

CNTN0.00x

TARA0.00x

Debt/Assets (TTM)

CNTN0.0%

TARA0.0%

Interest Coverage (TTM)

CNTNN/A

TARAN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

TARA0.00x

Beta

CNTN1.52

TARA1.54

52W Performance

CNTN-33.6%

TARA-45.7%

YTD Performance

CNTN-37.6%

TARA-48.8%

% from 52W High

CNTN-69.4%

TARA-64.8%

% from 52W Low

CNTN20.6%

TARA9.8%

Asset Turnover (TTM)

CNTN0.00x

TARA0.00x

FCF Yield (TTM)

CNTN-97.9%

TARA-42.9%

Earnings Yield (TTM)

CNTN-60.3%

TARA-45.2%

Dividend Yield (TTM)

CNTNN/A

TARAN/A

Rule of 40

CNTN-10,651.0

TARA0.0

EV/GP/RG

CNTNN/A

TARAN/A

Ticker research

View CNTN research View TARA research

Metric	CNTN Canton Strategic Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$163M	$155M
Enterprise Value	$125M	$138M
Price	$2.11	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	0.00x
EV/Sales	83.88x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	0.0%
Net Margin (TTM)	-6559.1%	0.0%
FCF Margin (TTM)	-10651.0%	N/A
Net Income (TTM)	$-98M	$-70M
FCF (TTM)	$-159M	$-66M
EPS (TTM)	-$0.45	-$1.15
ROE (TTM)	-2954.0%	-4172.0%
ROA (TTM)	-2342.0%	-3878.0%
ROIC (TTM)	-2953.0%	-4172.0%
Financial Health
Cash	$37M	$17M
Debt	$0	$0
Net Cash/Debt	$37M	$17M
Current Ratio (TTM)	15.70x	10.97x
Quick Ratio (TTM)	14.45x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.54
52W Performance	-33.6%	-45.7%
YTD Performance	-37.6%	-48.8%
% from 52W High	-69.4%	-64.8%
% from 52W Low	20.6%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-97.9%	-42.9%
Earnings Yield (TTM)	-60.3%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View TARA research

Valuation

P/S Ratio

TARA

0.00x

CNTN

108.78x

EV/FCF

TARA

-2.07x

CNTN

-0.79x

Growth & revenue

Forward Revenue Growth

TARA

5488.8%

CNTN

0.0%

Profitability & performance

Gross Margin

CNTN

0.0%

TARA

0.0%

ROE

CNTN

-2954.0%

TARA

-4172.0%

FCF Yield %

TARA

-42.9%

CNTN

-97.9%

52-Week Performance

CNTN

-33.6%

TARA

-45.7%

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

TARA

Protara Therapeutics Inc

Market Cap

CNTN$163M

TARA$155M

Enterprise Value

CNTN$125M

TARA$138M

Price

CNTN$2.11

TARA$2.76

P/E Ratio

CNTNN/A

TARAN/A

P/S Ratio

CNTN108.78x

TARA0.00x

EV/Sales

CNTN83.88x

TARA0.00x

EV/EBITDA

CNTN0.00x

TARA0.00x

P/B Ratio

CNTN0.39x

TARA0.99x

P/FCF Ratio

CNTNN/A

TARAN/A

EV/FCF

CNTN-0.79x

TARA-2.07x

PEG Ratio

CNTNN/A

TARAN/A

Forward P/E (NTM)

CNTNN/A

TARAN/A

Forward P/S (NTM)

CNTNN/A

TARAN/A

Revenue (TTM)

CNTN$1M

TARA$0

Revenue Growth (YoY)

CNTNN/A

TARAN/A

Forward Rev Growth

CNTN0.0%

TARA5488.8%

Gross Margin (TTM)

CNTN0.0%

TARA0.0%

Operating Margin (TTM)

CNTN0.0%

TARA0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

TARA0.0%

Net Margin (TTM)

CNTN-6559.1%

TARA0.0%

FCF Margin (TTM)

CNTN-10651.0%

TARAN/A

Net Income (TTM)

CNTN$-98M

TARA$-70M

FCF (TTM)

CNTN$-159M

TARA$-66M

EPS (TTM)

CNTN-$0.45

TARA-$1.15

ROE (TTM)

CNTN-2954.0%

TARA-4172.0%

ROA (TTM)

CNTN-2342.0%

TARA-3878.0%

ROIC (TTM)

CNTN-2953.0%

TARA-4172.0%

Cash

CNTN$37M

TARA$17M

Debt

CNTN$0

TARA$0

Net Cash/Debt

CNTN$37M

TARA$17M

Current Ratio (TTM)

CNTN15.70x

TARA10.97x

Quick Ratio (TTM)

CNTN14.45x

TARA10.81x

Debt/Equity (TTM)

CNTN0.00x

TARA0.00x

Debt/Assets (TTM)

CNTN0.0%

TARA0.0%

Interest Coverage (TTM)

CNTNN/A

TARAN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

TARA0.00x

Beta

CNTN1.52

TARA1.54

52W Performance

CNTN-33.6%

TARA-45.7%

YTD Performance

CNTN-37.6%

TARA-48.8%

% from 52W High

CNTN-69.4%

TARA-64.8%

% from 52W Low

CNTN20.6%

TARA9.8%

Asset Turnover (TTM)

CNTN0.00x

TARA0.00x

FCF Yield (TTM)

CNTN-97.9%

TARA-42.9%

Earnings Yield (TTM)

CNTN-60.3%

TARA-45.2%

Dividend Yield (TTM)

CNTNN/A

TARAN/A

Rule of 40

CNTN-10,651.0

TARA0.0

EV/GP/RG

CNTNN/A

TARAN/A

Ticker research

View CNTN research View TARA research

Metric	CNTN Canton Strategic Holdings Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$163M	$155M
Enterprise Value	$125M	$138M
Price	$2.11	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	0.00x
EV/Sales	83.88x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	0.0%
Net Margin (TTM)	-6559.1%	0.0%
FCF Margin (TTM)	-10651.0%	N/A
Net Income (TTM)	$-98M	$-70M
FCF (TTM)	$-159M	$-66M
EPS (TTM)	-$0.45	-$1.15
ROE (TTM)	-2954.0%	-4172.0%
ROA (TTM)	-2342.0%	-3878.0%
ROIC (TTM)	-2953.0%	-4172.0%
Financial Health
Cash	$37M	$17M
Debt	$0	$0
Net Cash/Debt	$37M	$17M
Current Ratio (TTM)	15.70x	10.97x
Quick Ratio (TTM)	14.45x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.54
52W Performance	-33.6%	-45.7%
YTD Performance	-37.6%	-48.8%
% from 52W High	-69.4%	-64.8%
% from 52W Low	20.6%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-97.9%	-42.9%
Earnings Yield (TTM)	-60.3%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View TARA research